Literature DB >> 2104591

An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for human growth hormone.

L Stefaneanu1, K Kovacs, E Horvath, N E Losinski, A Mayerhofer, T E Wagner, A Bartke.   

Abstract

Adenohypophysial morphology in 12 mice transgenic for methallothionein-I-human (h) GH fusion gene was investigated by immunocytochemistry and electron microscopy. The sustained oversecretion of hGH stimulated body growth. The pituitary glands of 6-month-old transgenic mice were significantly decreased in weight and showed marked morphological changes in somatotrophs, lactotrophs, corticotrophs, and gonadotrophs. GH-immunoreactive cells were greatly reduced in size and midly decreased in number; by electron microscopy, the organelles implicated in hormone synthesis were inconspicuous in this cell type. Transgenic males were hypoprolactinemic, presumably due to lactogenic activity of hGH in rodents. Their pituitaries displayed few and slender PRL-immunoreactive cells; ultrastructurally, they belonged to immature (type II) lactotrophs. However, in females, PRL-containing cells showed no change in number, size, or distribution compared to controls. Prior biochemical studies demonstrated high blood levels of LH in males. Their pituitaries contained highly active gonadotrophs resembling gonadectomy cells, consistent with the view that these changes are related to PRL-like activity of hGH in mice. In both sexes, stimulated corticotrophs were present. The results indicate that some changes in adenohypophysial cells of mice transgenic for hGH can be attributed to protracted overproduction of the heterologous GH, whereas others can be explained by lactotrophic activity of hGH in mice. The divergent morphological responses of lactotrophs and gonadotrophs in the two sexes may reflect differences in the hormonal regulatory mechanisms between male and female mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104591     DOI: 10.1210/endo-126-1-608

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Effects of overexpression of growth hormone-releasing hormone on the hypothalamo-pituitary-gonadal function in the mouse.

Authors:  L Debeljuk; R W Steger; J C Wright; J Mattison; A Bartke
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

Review 2.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

3.  Differential in vivo activities of bovine growth hormone analogues.

Authors:  J Kopchick; X Z Chen; Y Li; R W Steger; J S Yun; T E Wagner; A Bartke
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

4.  Cysts in the rat adenohypophysis: incidence and histology.

Authors:  A Quintanar-Stephano; L Muñoz Fernández; J L Quintanar; K Kovacs
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Studies on the thyroid in transgenic mice expressing the genes for human and bovine growth hormone.

Authors:  A Mayerhofer; S Easterly; A G Amador; J Gher; A Bartke; J Yun; T E Wagner
Journal:  Experientia       Date:  1990-10-15

6.  Lactotroph hyperplasia in the pituitaries of female mice expressing high levels of bovine growth hormone.

Authors:  S Vidal; L Stefaneanu; K Thapar; R Aminyar; K Kovacs; A Bartke
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

7.  Mitotic Counts in Rat Adenohypophysial Thyrotrophs and Somatotrophs: Effects of Short-Term Thyroidectomy, Thyroxine, and Thyrotropin-Releasing Hormone.

Authors:  Andrés Quintanar-Stephano; Carlos Valverde-R; Kalman Kovacs
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.